Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.

High-risk neuroblastoma PDX models can be reliably established from diverse sample types. Orthotopic implantation allows more rapid model development, increasing the likelihood of developing an avatar model within a clinically useful timeframe.